Clinical Trial Update: SUBLOCADE Rapid Initiation Extension Study [Phase 4]

View source ↗

Summary

Phase 4 trial update for SUBLOCADE evaluating rapid initiation extension in adults with opioid use disorder; the study is completed with results posted in Janua…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• SUBLOCADE (buprenorphine extended-release)

Snippet

Sponsor: Indivior Inc. | Conditions: Opioid Use Disorder, Severe, Opioid Use Disorder, Moderate | Phase 4 | Status: COMPLETED | Results posted: 2021-01-25